11β hydroxytestosterone 11oht (steraloids inc)
Structured Review

11β Hydroxytestosterone 11oht, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/A5760-000/4-ANDROSTEN-11%CE%B2%2C+17%CE%B2-DIOL-3-ONE/bio_rxiv__64898__2026__03__27__714735-107-14-22
Average 93 stars, based on 20 article reviews
Images
1) Product Images from "Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women"
Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
Journal: bioRxiv
doi: 10.64898/2026.03.27.714735
Figure Legend Snippet: Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and 11OHT) over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).
Techniques Used: Incubation, Liquid Chromatography with Mass Spectroscopy
Figure Legend Snippet: Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and 11OHT) over the classic androgen (T). Adipose tissue was collected from women undergoing ( A & B ) bariatric surgery (n=8, age 32-59, BMI 42.0-56.8 kg/m ) and ( C & D ) gynecological surgery (n=22, age 36-63, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynae surgery). Androgen metabolites were quantified by LC-MS/MS. ( E ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT; n=8 or 9). Bars show the mean of all independent experiments ± IQR; circles represent the results in individual adipose tissue explants ( A-D ) or independent cell culture experiments ( E ).
Techniques Used: Incubation, Liquid Chromatography with Mass Spectroscopy, Cell Culture
Figure Legend Snippet: ( A ) Inhibitor dose-response curves of AKR1C3 activity for the A4 to T and 11KA4 to 11KT reactions. HEK293T cells were transfected to express AKR1C3 and treated with either A4 or 11KA4 (100 nM) and increasing concentration of the AKR1C3 inhibitor BAY2299242 (BAY2) (n=3). Mean values with SEM as percentage of uninhibited activity are shown. A non-linear fit with the Four-Parameter Logistic (4PL) regression model with the slope parameter set to 1 was made to the model and the sigmoidal curve displays the 100% + response value with a 95% confidence interval. ( B & C ) A luciferase reporter assay in HEK293 cells transfected to constitutively express AKR1C3 and the AR, as well as luciferase under the control of an androgen response element, shows that AKR1C3 inhibition with BAY2 blocks AR transactivation in response to A4 and 11KA4 (n=4). Mean and SEM are shown. P-values were determined with a paired, two-tailed t-test. ( D & E ) Selective inhibition of 11-oxygenated androgen activation with BAY2 (300 nM) in female subcutaneous or visceral adipose tissue (n=22 donors, age 36-63, BMI 20.8-38.2 kg m - ) incubated ex vivo with androstenedione or 11KA4 (100 nM). Bars show the mean of all independent replicates ± SEM; circles represent the individual tissue donors. P-values were determined using Wilcoxon matched-pairs signed rank test. ( F & G ) In silico prediction of AKR1C3 inhibition in adipose tissue shows. A computational model of adipose tissue androgen metabolism by AKR1C3 and HSD11B1 was fitted to the experimental conversion data from the ex vivo subcutaneous ( F ) and visceral ( G ) adipose experiments from D & E in the absence of the AKR1C3 inhibitor (n=22). The reduction in AKR1C3 activity up to its fitted level of inhibition was then simulated and compared to the inhibition achieved in the ex vivo experiments with 300 nM BAY2 for each individual donor. The experimental data is shown as individual data points (open circles), while the model’s simulations of increasing AKR1C3 inhibition are shown by the connecting black lines. The colored lines and shaded areas show the median and median absolute deviation of the model’s predictions. The data is shown as the ratio of AKR1C3 substrates over total classic (A4 / (A4 + T) or 11-oxygenated androgens (11KT + 11OHT) / (11OHA4 + 11KA4 + 11KT + 11OHT)).
Techniques Used: Activity Assay, Transfection, Concentration Assay, Luciferase, Reporter Assay, Control, Inhibition, Two Tailed Test, Activation Assay, Incubation, Ex Vivo, In Silico
Figure Legend Snippet: ( A ) Schematic showing the AKR1C3-catalyzed conversions for 11-oxygenated androgens (red) and classic androgens (blue). Serum concentrations of testosterone, 11-ketotestosterone and 11β-hydroxytestosterone over the 12 weeks of treatment with either 60 mg BAY1128688 (BAY1) taken orally twice daily (n=9) or placebo (n=12). Panels B-D show the acute androgen response to BAY1 and placebo within 4 hours of oral intake of inhibitor or placebo at baseline (=first dose) and after 12 weeks of treatment with no effect on testosterone but decreases in the circulating concentrations of 11KT and 11OHT at 2 and 4 hours. Panels E-G show the morning serum concentrations of active androgens during the 12-week treatment period and 6 weeks after the end of treatment (=EoT) with the AKR1C3 inhibitor or placebo. Serum steroid levels were quantified by LC-MS/MS. The arrow indicates the timing of inhibitor or placebo administration. Boxes show the median and 25 th -75 th percentile, whiskers the range. Circles represent the individual participants. The dotted line indicates the lower limit of quantification for the respective analyte.
Techniques Used: Liquid Chromatography with Mass Spectroscopy
Figure Legend Snippet: Women received either 60 mg BAY1 twice daily (n=9) or placebo (n=12). (A) Schematic showing the AKR1C3 catalyzed conversions for 11-oxygenated androgens (red) and classic androgens (blue). Serum levels of (B-E) 11-oxygenated androgens and (F-J) classic androgens quantified by LC-MS/MS show acute decreases in the active 11-oxygenated androgens (11KT and 11OHT, D & E) without discernible acute effect on classic androgens. The arrow indicates the timing of inhibitor or placebo administration. Boxes show the median and 25th-75th percentile, whiskers the range. Closed circles represent the individual participants. The dotted line indicates the lower limit of quantification of the LC-MS/MS assay.
Techniques Used: Liquid Chromatography with Mass Spectroscopy
Related Articles
Incubation:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Liquid Chromatography with Mass Spectroscopy:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Cell Culture:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Activity Assay:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Transfection:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Concentration Assay:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Luciferase:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Reporter Assay:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Control:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Inhibition:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Two Tailed Test:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Activation Assay:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and Ex Vivo:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and In Silico:Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and |
